Menu
Search
|

Menu

Close
X

Knight Therapeutics Inc GUD.TO (Toronto Stock Exchange)

8.59 CAD
-- (--)
As of Jul 16
chart
Previous Close 8.59
Open --
Volume --
3m Avg Volume 136,969
Today’s High --
Today’s Low --
52 Week High 10.24
52 Week Low 7.38
Shares Outstanding (mil) 142.77
Market Capitalization (mil) 1,252.05
Forward P/E 59.75
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 10 analysts

KEY STATS

Revenue (mm, CAD)
FY18
3
FY17
9
FY16
6
FY15
1
EPS (CAD)
FY18
0.048
FY17
0.120
FY16
0.146
FY15
0.359
*Note: Units in Millions of Canadian Dollars
**Note: Units in Canadian Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
59.75
32.76
Price to Sales (TTM)
vs sector
157.15
5.73
Price to Book (MRQ)
vs sector
1.28
5.45
Price to Cash Flow (TTM)
vs sector
59.49
23.29
Total Debt to Equity (MRQ)
vs sector
0.00
16.72
LT Debt to Equity (MRQ)
vs sector
0.00
12.39
Return on Investment (TTM)
vs sector
2.19
14.61
Return on Equity (TTM)
vs sector
2.19
16.34

EXECUTIVE LEADERSHIP

Samira Sakhia
President, Director, Since 2016
Salary: $73,702.00
Bonus: --
Jonathan Goodman
Chief Executive Officer, Director, Since 2013
Salary: $300,000.00
Bonus: --
Jeffrey Kadanoff
Chief Financial Officer, Since
Salary: $225,000.00
Bonus: --
Amal Khouri
Vice President - Business Development, Since
Salary: $225,000.00
Bonus: --
Meir Jakobsohn
Director, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

3400 De Maisonneuve West
MONTREAL   QC   H3Z 3B8

Phone: +1514.4844483

Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.

SPONSORED STORIES